Answers are grounded in this paper and cite their sources.
Background: The prognosis of breast cancer is poor, especially in African American women. The increase in the proportion of cancer stem cells (CSCs) is considered to be one of the important mechanisms of breast cancer chemotherapy resistance. The study aims to explore the expression of hub genes related to breast cancer stem cells (BCSCs), molecular mechanisms regulating the occurrence and development of breast cancer, and novel targeted therapies. Methods: The gene data of African American breast cancer were downloaded from TCGA and GEO. First, the differential expressions of the samples were analyzed by log-rank tests and in the “edgeR” R package. Then, we constructed a WGCNA to screen key genes extracted from the modules of interest. GO enrichment and KEGG pathway analysis were performed for functional and pathway enrichment. Finally, the microarray database Oncomine was used for the analysis of the differential expression of hub genes. Results: African American breast cancer cell samples showed a significant increase in mRNAsi and the patients with high mRNAsi expression levels had a lower survival rate than those with normal tissues. Selected differential genes were analyzed by WGCNA and 33 hub genes with similar functions were selected from the modules: TTK , NCAPG , KIF2C and so on. Functional enrichment analysis showed that hub genes were mainly associated with cell proliferation. Oncomine analysis showed that their expression levels in triple-negative breast cancer were significantly higher than those in non-triple negative breast cancer. Conclusions: In summary, African American breast cancer cells with high expression levels of TTK , NCAPG , KIF2C responded better to docetaxel chemotherapy than those with low expression levels.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: